Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
Anaphylaxis secondary to thymoglobulin (anti-thymocyte globulin) is a rare condition that can be life threatening. Thymoglobulin is a rabbit-derived T-cell depleting polyclonal immunoglobulin. It is commonly used for induction immunosuppression and/or for treatment of acute rejection in renal transp...
Main Authors: | Muhammad I. Saeed, Ryan D. Nicklas, Vikas Kumar, Rajan Kapoor, Imran Y. Gani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/9/3/43 |
Similar Items
-
Continuity of Care Following Intraoperative Cardiac Arrest due to Thymoglobulin®-induced Anaphylaxis
by: Jose R Navas-Blanco, et al.
Published: (2018-04-01) -
Anaphylaxis: the current state of knowledge
by: Rafał Czyż, et al.
Published: (2018-09-01) -
Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01) -
Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
by: Jiang Qiu, et al.
Published: (2019-03-01) -
Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
by: Hui-Ying Liu, et al.
Published: (2019-08-01)